Skip to main content

Table 3 EPS cases complicated with esophageal cancer

From: Esophageal papillomatosis: an exceedingly rare disease

Source

Age

Sex

Esophageal cancer involvement

Pathology

Therapy

Van Cutsem et al. [26]

69

F

Middle

Dysplasia and invasive epithelial cell nests

Esophagectomy

Nd-Yag laser

Photocoagulation

Alpha-interferon treatment

HPMPC local injection

Waluga et al. [51]

28

M

Proximal

Poor-differentiated ESCC

N

Wolfsen et al. [43]

84

M

Distal

Microinvasive well-differentiated ESCC

PDT

Metal stent placement

Reynoso et al. [56]

74

F

Middle

In-situ ESCC with microinvasion into the lamina propria

Esophagectomy

Kao et al. [52]

70

F

Middle

Invasive ESCC

Repeated dilatation

Metal stent placement

Saravanan et al. [15]

60

M

Distal

Invasive well-differentiated ESCC with dysplasia

Esophagectomy

Attila et al. [57]

70

M

Middle

Invasive well-differentiated ESCC

EMR

Esophagectomy

Donnellan et al. [48]

64

F

Middle

Invasive ESCC

Chemoradiotherapy

Pohl [58]

72

F

Middle

ESCC

Esophagectomy

APC

endoscopic mucosectomy

Tanimu et al. [53]

51

M

Distal

ESCC

EMR, APT, PDT,

Radiofrequency ablation Esophagectomy

Bronswijk et al. [59]

47

M

Proximal

ESCC

Radiochemotherapy

Hafiz et al. [39]

37

F

Distal

Moderately differentiated invasive ESCC

Chemoradiotherapy

Esophagectomy

  1. PDT photodynamic therapy, ESCC esophageal squamous cell carcinoma, EMR endoscopic mucosal resection, APC argon plasmacoagulation, HPMPC (S)-l-(3-hydroxy-2-phosphonylmethoxypropy1)cytosine, N not mention